Bristol-Myers Squibb Company (BMY) Q1 2020 Earnings Results

Bristol-Myers Squibb Beats on EPS, Stock Down 0.15%

Bristol-Myers Squibb reported better-than-expected earnings per share, which indicates strong performance in that area. However, the stock reacted slightly negatively, declining by 0.15%. The lack of revenue data and management commentary may have contributed to the muted stock reaction.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.72	N/A	+16.37%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Bristol-Myers Squibb Beats on EPS, Stock Down 0.15%

Key numbers

Management commentary

Bristol-Myers Squibb Company

More earnings this week

Bristol-Myers Squibb Beats on EPS, Stock Down 0.15%

Key numbers

Management commentary